Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03920293 |
|---|---|
| Brief Title: | Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis |
| First Submitted : | April 16, 2019 |
| First Submitted that Met QC Criteria : | April 16, 2019 |
| First Posted : | April 18, 2019 |
| Results First Submitted : | May 3, 2022 |
| Results First Submitted that Met QC Criteria : | May 3, 2022 |
| Results First Posted : | May 26, 2022 |
| Certification/Extension First Submitted : | March 11, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | March 11, 2022 |
| Certification/Extension First Posted : | March 15, 2022 |
| Last Update Submitted that Met QC Criteria : | August 16, 2023 |
| Last Update Posted : | August 29, 2023 |